ELEVANCE HEALTH, INC. vs HUMANA INC, two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ELV and HUM diverge most: on net margin, ELV reads 2.5% and HUM reads 0.8%; on fcf yield, ELV reads 7.7% and HUM reads 2.9%. The rest of the comparable metrics sit closer together. What ELV's price implies is a bet that sits within the historical range (earnings-power basis). The bull and bear cases for each are in their full reports below.
| Metric | ELV | HUM |
|---|---|---|
| Price | $375.86 | $363.85 |
| Market cap | $81.9B | $43.9B |
| Sector | Managed Care | Managed Care |
| Stage | Mature | Growth |
| P/E | 16.6 | — |
| P/B | 1.82 | 2.35 |
| P/S | 0.41 | 0.32 |
| EV/EBITDA | 18.9 | 16.5 |
| Revenue growth | +6.5% | +13.9% |
| Operating margin | 3.5% | 4.4% |
| Net margin | 2.5% | 0.8% |
| Return on equity | 11.0% | 6.1% |
| Return on assets | 3.9% | 2.0% |
| Return on invested capital | 5.3% | 5.9% |
| FCF yield | 7.7% | 2.9% |
| Dividend yield | 1.6% | 1.0% |
| Debt / equity | 0.70 | 0.75 |
| Current ratio | 1.52 | 1.77 |
| Altman Z (solvency) | 2.86 | 4.43 |
| Piotroski F (quality) | 7 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.